Search Results - Ben Ke

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Association of nocturia of self-report with estimated glomerular filtration rate: a cross-sectional study from the NHANES 2005–2018 by Jianling Song, Ben Ke, Xiangdong Fang

    Published in Scientific Reports (2023-08-01)
    Get full text
    Article


  2. 2

    Identification of molecular mediators of renal sarcopenia risk: a mendelian randomization analysis by Peng Yan, Ben Ke, Xiangdong Fang

    Published in The Journal of Nutrition, Health and Aging (2024-01-01)
    Get full text
    Article


  3. 3

    Ion channels as a therapeutic target for renal fibrosis by Peng Yan, Ben Ke, Xiangdong Fang

    Published in Frontiers in Physiology (2022-10-01)
    Get full text
    Article


  4. 4

    Bioinformatics reveals the pathophysiological relationship between diabetic nephropathy and periodontitis in the context of aging by Peng Yan, Ben Ke, Xiangdong Fang

    Published in Heliyon (2024-01-01)
    Get full text
    Article


  5. 5

    MG53: A potential therapeutic target for kidney disease by Ben Ke, Wen Shen, Jianling Song, Xiangdong Fang

    Published in Pharmacology Research & Perspectives (2023-02-01)
    Get full text
    Article


  6. 6

    Roles of interferon regulatory factor 4 in the AKI-CKD transition, glomerular diseases and kidney allograft rejection by Jianling Song, Ben Ke, Weiping Tu, Xiangdong Fang

    Published in Renal Failure (2023-12-01)
    Get full text
    Article


  7. 7

    Identification of immune-related molecular clusters and diagnostic markers in chronic kidney disease based on cluster analysis by Peng Yan, Ben Ke, Jianling Song, Xiangdong Fang

    Published in Frontiers in Genetics (2023-02-01)
    Get full text
    Article


  8. 8

    Mendelian randomization analysis reveals higher whole body water mass may increase risk of bacterial infections by Peng Yan, Jiahuizi Yao, Ben Ke, Xiangdong Fang

    Published in BMC Medical Genomics (2024-07-01)
    Get full text
    Article


  9. 9

    Abnormalities in the SIRT1-SIRT3 axis promote myocardial ischemia-reperfusion injury through ferroptosis caused by silencing the PINK1/Parkin signaling pathway by Yunfei Liao, Ben Ke, Xiaoyan Long, Jianjun Xu, Yongbing Wu

    Published in BMC Cardiovascular Disorders (2023-11-01)
    Get full text
    Article


  10. 10

    Management of rituximab in patients with PLA2R-associated membranous nephropathy of different age: a single-center retrospective cohort study by Xueting Li, Lei Song, Le Wang, Ben Ke, Wen Shen

    Published in Renal Failure (2025-12-01)
    Get full text
    Article


  11. 11

    Dickkopf-3: Current Knowledge in Kidney Diseases by Xiangdong Fang, Jing Hu, Yanxia Chen, Wen Shen, Ben Ke

    Published in Frontiers in Physiology (2020-12-01)
    Get full text
    Article


  12. 12

    Peli1, regulated by m6A modification, suppresses NLRP3 inflammasome activation in atherosclerosis by inhibiting YB-1 by Qiang Liu, Lu Yan, Tao Wu, Qinghua Wu, Ben Ke, Wen Shen

    Published in Communications Biology (2025-03-01)
    Get full text
    Article


  13. 13

    VEGFA promotes the occurrence of PLA2R-associated idiopathic membranous nephropathy by angiogenesis via the PI3K/AKT signalling pathway by Ben Ke, Jinjing Huang, Zhibing Duan, Wen Shen, Yao Wu, Weiping Tu, Xiangdong Fang

    Published in BMC Nephrology (2022-09-01)
    Get full text
    Article


  14. 14

    LncRNA SNHG1 knockdown inhibits hyperglycemia induced ferroptosis via miR‐16‐5p/ACSL4 axis to alleviate diabetic nephropathy by Xiangdong Fang, Jianling Song, Yanxia Chen, Shuying Zhu, Weiping Tu, Ben Ke, Lidong Wu

    Published in Journal of Diabetes Investigation (2023-09-01)
    Get full text
    Article


  15. 15

    DKK3 promotes renal fibrosis by increasing MFF-mediated mitochondrial dysfunction in Wnt/β-catenin pathway-dependent manner by Jianling Song, Yanxia Chen, Yan Chen, Minzi Qiu, Wenliu Xiang, Ben Ke, Xiangdong Fang

    Published in Renal Failure (2024-12-01)
    Get full text
    Article


  16. 16

    The efficacy and safety of half-dose glucocorticoids combined with rituximab versus high-dose glucocorticoids for initial treatment of minimal change disease: a single-center exper... by Xueting Li, Peng Yan, Lu Zhang, Wei Qiao, Zhengbiao Xue, Xiangdong Fang, Ben Ke, Shuying Zhu

    Published in Frontiers in Pharmacology (2025-01-01)
    Get full text
    Article


Search Tools: